Industry scouting for best outcome for EU medical technology companies facing dual compliance task
This article was originally published in Clinica
Device companies operating in the EU that are likely to be affected by the overlap in essential requirements under the revised medical devices and active implantables directives (93/42 and 90/385) and the machinery Directive 2006/42 (see Clinica No 1263, p 1) will probably not be able to rely on last-minute help from the EU Council.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.